Sunshine Biopharma (SBFM) Long-Term Deferred Tax (2022 - 2025)

Sunshine Biopharma has reported Long-Term Deferred Tax for 3 years, with the latest figure at $92234.0 in Q3 2025.

• For the quarter ending Q3 2025, Long-Term Deferred Tax changed N/A year-over-year to $92234.0; the trailing twelve-month figure through Sep 2025 stood at $92234.0 (changed N/A YoY), and the FY2024 full-year result was $92234.0, changed N/A from the prior year.
• Long-Term Deferred Tax for Q3 2025 stood at $92234.0, roughly flat from $92234.0 in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $92234.0 in Q4 2024, with the low at $43032.0 in Q4 2022.
• Historically, Long-Term Deferred Tax has averaged $82393.6 across 3 years, with a median of $92234.0 in 2024.